1,361 reports of this reaction
2.7% of all CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE reports
#6 most reported adverse reaction
ARTHRALGIA is the #6 most commonly reported adverse reaction for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, manufactured by Sandoz Inc. There are 1,361 FDA adverse event reports linking CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE to ARTHRALGIA. This represents approximately 2.7% of all 49,809 adverse event reports for this drug.
Patients taking CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE who experience arthralgia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ARTHRALGIA is a less commonly reported adverse event for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, but still significant enough to appear in the safety profile.
In addition to arthralgia, the following adverse reactions have been reported for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE:
The following drugs have also been linked to arthralgia in FDA adverse event reports:
ARTHRALGIA has been reported as an adverse event in 1,361 FDA reports for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ARTHRALGIA accounts for approximately 2.7% of all adverse event reports for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, making it a notable side effect.
If you experience arthralgia while taking CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.